# Develo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/develo

- Industry: Software
- Headquarters: Los Angeles, US
- Website: www.develo.com
- Total disclosed funding: $10M
- Latest round: Series A (Feb 19, 2026)
- Investors on record: 4

## About

Develo Inc., based in the US, is a software company specializing in innovative solutions for independent pediatric practices, enhancing operational efficiency and patient engagement through advanced technology. Founded in 2022 and headquartered in Los Angeles, US, Co founded by Aaron Sin, MD and Han Ke. Develo Inc. provides software solutions tailored specifically for pediatric practices. The company raised USD 9.99 mn in series A funding round on February, 2026, led by Blueprint Equity, with participation from Bienville Capital Management, Villain Capital, and Z21 Ventures. Develo offers a comprehensive suite of software solutions specifically designed for independent pediatric practices, addressing various operational needs such as electronic medical records (EMR), scheduling, billing, and family engagement. The core product is a FHIR-native interoperable system that streamlines clinical documentation and automates patient throughput to enhance practice efficiency. The software also supports adolescent confidentiality and family management through a consumer-first, digital-enabled approach. Develo serves a diverse client base, primarily composed of independent pediatricians and their practices across the United States. The solutions are engineered to optimize practice operations, improve patient interactions, and ultimately foster revenue growth, with a reported average net revenue increase of 20% for users.Develo operates on a subscription-based revenue model, charging a monthly fee per practitioner for access to its all-inclusive software suite. This pricing structure is designed to simplify budgeting for pediatric practices, eliminating unexpected add-on fees. Client transactions typically involve signing up for the service, which includes pre-go-live data migration, ongoing system updates, and user training, ensuring a seamless integration process. The company emphasizes a straightforward approach to pricing, offering comprehensive service packages that enhance productivity and financial performance for practices. This model positions Develo to create lasting relationships with clients, driving consistent revenue through its tailored solutions for independent pediatric practices.In February 2026, Develo Inc. raised USD 9.99 mn in series A funding, which will be utilized to accelerate product development, invest in research and development, and expand customer support operations. The company aims to further enhance its software offerings and is actively exploring expansion into new geographic regions to broaden its market reach.

## Funding rounds

- Series A, Feb 19, 2026, $10M — Bienville Capital Management, Blueprint Equity, Z21 Ventures, Villain Capital

## Investors

- Bienville Capital Management (https://capitalatlas.ai/funds/bienville-capital-management) — Series A
- Blueprint Equity (https://capitalatlas.ai/funds/blueprint-equity) — Series A
- Z21 Ventures (https://capitalatlas.ai/funds/z21-ventures) — Series A
- Villain Capital (https://capitalatlas.ai/funds/villain-capital) — Series A